T-Cell Repertoire Analysis in the Conjunctiva of Murine Dry Eye Model.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 03 2023
Historique:
entrez: 6 3 2023
pubmed: 7 3 2023
medline: 9 3 2023
Statut: ppublish

Résumé

Dry eye is closely related to the activation and proliferation of immune cells, especially T cells. However, the determination of the preferential T-cell clonotypes is technically challenging. This study aimed to investigate the characterization of T-cell receptor (TCR) repertoire in the conjunctiva during dry eye. A desiccating stress animal model was established using C57/BL6 mice (8-10 weeks, female). After 7 days of stress stimulation, the slit-lamp image and Oregon-green-dextran staining were used to evaluate the ocular surface injury. Periodic acid-Schiff staining was used to measure the number of goblet cells. Flow cytometry was used to detect the activation and proliferation of T cells in the conjunctiva and cervical lymph nodes. Next-generation sequencing was used to detect the αβ TCR repertoire of the conjunctiva. The αβ TCR diversity increased significantly in the dry eye group, including the higher CDR3 amino acid length, marked gene usage on TCR V and J gene segments, extensive V(D)J recombination, and distinct CDR3 aa motifs. More important, several T-cell clonotypes were uniquely identified in dry eye. Furthermore, these perturbed rearrangements were reversed after glucocorticoid administration. A comprehensive analysis of the αβ TCR repertoire in the conjunctiva of the dry eye mouse model was performed. Data in this study contributed significantly to the research on dry eye pathogenesis by demonstrating the TCR gene distribution and disease-specific TCR signatures. This study further provided some potential predictive T-cell biomarkers for future studies.

Identifiants

pubmed: 36877515
pii: 2785421
doi: 10.1167/iovs.64.3.14
pmc: PMC10007900
doi:

Substances chimiques

Povidone FZ989GH94E
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14

Références

Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4898-4907
pubmed: 28973340
Oncoimmunology. 2016 Aug 5;5(10):e1219010
pubmed: 27853640
Blood. 2009 Nov 5;114(19):4099-107
pubmed: 19706884
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2553-60
pubmed: 17525184
J Virol. 2020 Sep 29;94(20):
pubmed: 32759317
Eur J Immunol. 1991 Mar;21(3):643-8
pubmed: 1826261
Nucleic Acids Res. 1990 Oct 25;18(20):6097-100
pubmed: 2172928
Front Immunol. 2019 Oct 31;10:2549
pubmed: 31736968
Int Immunol. 2004 Mar;16(3):423-31
pubmed: 14978016
J Immunol. 2006 Apr 1;176(7):3950-7
pubmed: 16547229
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3293-302
pubmed: 16877394
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6056-6064
pubmed: 29204644
J Autoimmun. 2020 May;109:102432
pubmed: 32115259
Nat Rev Clin Oncol. 2021 Apr;18(4):215-229
pubmed: 33473220
Front Immunol. 2020 Sep 30;11:582010
pubmed: 33117392
Clin Immunol. 2018 Jul;192:58-67
pubmed: 29679709
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2847-56
pubmed: 16799024
Blood. 2021 May 13;137(19):2585-2597
pubmed: 33270816
Mucosal Immunol. 2019 Jul;12(4):897-908
pubmed: 30696983
Ocul Surf. 2021 Jan;19:157-168
pubmed: 32470612
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
J Immunol. 2015 Oct 1;195(7):3086-99
pubmed: 26324767
J Immunol. 1995 Oct 15;155(8):4084-9
pubmed: 7561120
J Anat. 2005 Mar;206(3):271-85
pubmed: 15733300
Nat Med. 2019 Jan;25(1):89-94
pubmed: 30510250
J Immunol. 1990 Dec 15;145(12):4037-45
pubmed: 1979585
Genome Med. 2013 Oct 30;5(10):98
pubmed: 24172704
Front Immunol. 2020 Jan 29;11:12
pubmed: 32117220
Nat Immunol. 2019 Sep;20(9):1220-1230
pubmed: 31285626
J Immunother Cancer. 2018 Jun 11;6(1):51
pubmed: 29891009
Immunology. 1994 Apr;81(4):497-501
pubmed: 8039804
JCI Insight. 2016 Jun 2;1(8):
pubmed: 27358913
Am J Ophthalmol. 2012 Jul;154(1):63-71
pubmed: 22541929
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3802-7
pubmed: 19339740
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Int Ophthalmol Clin. 2017 Spring;57(2):109-118
pubmed: 28282318
Sci Rep. 2018 Jan 18;8(1):1058
pubmed: 29348598
Autoimmun Rev. 2021 Nov;20(11):102933
pubmed: 34509656
Nat Commun. 2017 Nov 27;8(1):1792
pubmed: 29176645
Mucosal Immunol. 2022 Apr;15(4):620-628
pubmed: 35361907
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2609-14
pubmed: 12147592
Semin Immunopathol. 2017 Apr;39(3):255-268
pubmed: 28074285
Ocul Surf. 2017 Jul;15(3):276-283
pubmed: 28736335
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14447-52
pubmed: 9826720
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3259-3268
pubmed: 29971445
J Immunol. 2009 Feb 1;182(3):1247-52
pubmed: 19155469
Hepatology. 2018 Nov;68(5):1977-1990
pubmed: 29704254
Cancer Res. 2020 Feb 15;80(4):643-654
pubmed: 31888887
Ocul Surf. 2017 Jul;15(3):438-510
pubmed: 28736340
EBioMedicine. 2019 Sep;47:414-426
pubmed: 31477563
Exp Eye Res. 2020 Dec;201:108294
pubmed: 33039458

Auteurs

Xiaorui Bao (X)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

Yanlin Zhong (Y)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

Chunyan Yang (C)

School of Life Science, Xiamen University, Xiamen, Fujian, China.

Yujie Chen (Y)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.

Yi Han (Y)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

Xiang Lin (X)

Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

Caihong Huang (C)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

Kejia Wang (K)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.

Zuguo Liu (Z)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.
The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.

Cheng Li (C)

Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH